Technology
Health
Biotechnology

Vaccinex

116

$6.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.50%) Today
+$0.19 (+3.17%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Vaccinex and other stocks, options, ETFs, and crypto commission-free!

About VCNX

Vaccinex, Inc. Common Stock, also called Vaccinex, is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Read More Te firm focuses in the development of pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma and Huntington's disease. Its products pipeline include SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer and Deepak Sahasrabudhe in 1997 and is headquartered in Rochester, NY.

CEO
Maurice Zauderer
Employees
44
Headquarters
Rochester, New York
Founded
1997
Market Cap
89.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.14K
High Today
$6.07
Low Today
$5.97
Open Price
$6.07
Volume
1.46K
52 Week High
$8.49
52 Week Low
$3.32

Collections

Technology
Health
Biotechnology
Medical
Cancer Prevention
2018 IPO
US
North America

VCNX Earnings

-$1.62
-$1.33
-$1.04
-$0.75
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 12, Pre-Market
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy VCNX

Market Price$6.18
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Vaccinex stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up